Articles | Open Access |

POLYMORPHISM OF THE E NOS GENE IN COVID-19 PATIENTS WITH METABOLIC SYNDROME

Tashkenbaeva Eleonora Negmatovna , DSc, professor head of the Department of Internal Diseases and cardiology
Abdieva Gulnora Alievna , № 2 , Samarkand State Medical University , Samarkand, Uzbekistan Assistant of the Department of Internal Diseases and cardiology
Ergashev Аrslanbek , № 2 , Samarkand State Medical University , Samarkand, Uzbekistan 6th year student of the Faculty of Medicine No. 1

Abstract

This analysis will not only more accurately determine the nature of the development of the metabolic syndrome, the progression of coronary artery disease, but will also help to identify the impact of 2019-nCoV infection on heart damage.

Keywords

COVID-19, metabolic syndrome, coronary artery disease, comorbidity, cardiovascular complications.

References

Abdieva G.A., Tashkenbaeva E.N. Influence of metabolic and cardiovascular diseases on the course of COVID -19 // Journal of cardiorespiratory research 2022. Volume 3, Issue 2, 33-37.

Abdieva G.A., Tashkenbaeva E.N. Influence of SARS - CoV -2 on the course of coronary heart disease against the background of metabolic syndrome // Journal of cardiorespiratory research 2022. SI 1.1, 8-15.

Tashkenbaeva E.N., Abdieva G.A., Khaidarova D.D., Saidov M.A. , Yusupova M.F. The prevalence of metabolic syndrome in patients with coronary heart disease // Journal of cardiorespiratory research 2021. Volume 2, Issue 1., 85-88.

Tashkenbayeva E. et al. ASSOCIATED RISK FACTORS FOR CARDIOVACULAR EVENT IN POST-MENOPAUSAL WOMEN //Journal of Cardiorespiratory Research. - 2020. - Vol. 1. - No. 3. - S. 33-39.

Togaeva B. et al. COVID-19 YURAK QON TOMIR KASALLIKLARI BOR BEMORLARDA KECHISHI // Journal of Cardiorespiratory Research. - 2021. - Vol. 2. - No. 2. - S. 47-50.

Abdieva Gulnora Alievna , & Tashkenbaeva Eleonora Negmatovna . (2023). 2DSc, professor head of the Department of Internal Diseases and cardiology №2, Samarkand State Medical University, Samarkand, Uzbekistan. https://doi.org/10.5281/zenodo.7803642

Ahmad T, Chaudhuri R, Joshi MC, Almatroudi A, Rahmani AH, Ali SM. 2020a. Ali SM.COVID -19: The Emerging Immunopathological Determinants for Recovery or Death. Frontiers in Microbiology 11:588409. DOI: https:// doi.org/10.3389/fmicb.2020.588409 , PMID: 33335518

Ahmad T, Haroon H, Baig M, Hui J. 2020b. Coronavirus Disease 2019 (COVID-19) Pandemic and Economic Impact. Pakistan Journal of Medical Sciences 36:32582318. DOI: https://doi.org/10.12669/pjms.36.COVID19- S4.2638

Chen X, Xiang M, Zhang C, Bai L, Xiang D, Chen MM, Liu Y, et al. 2020. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. cell Metabolism 31:1068-1077 .. DOI: https://doi.org/10.1016/j.cmet.2020.04.021

Klypa TV, Bychinin MV, Mandel IA, Andreichenko SA, Minets AI, Kolyshkina NA, Troitsky AV Clinical characteristics of patients admitted to an ICU with COVID-19. Predictors of the severe disease // Journal of Clinical Practice. - 2020. - Vol. 11. - N. 2. - P. 6-20. doi : 10.17816/clinpract34182

Yang X., Yu Y., Xu J., Shu H., Xia J., Liu H., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respirator Med . 2020 May;8(5):475–481.

Article Statistics

Downloads

Download data is not yet available.

Copyright License

Download Citations

How to Cite

POLYMORPHISM OF THE E NOS GENE IN COVID-19 PATIENTS WITH METABOLIC SYNDROME. (2024). International Bulletin of Medical Sciences and Clinical Research, 4(2), 23-33. https://researchcitations.com/index.php/ibmscr/article/view/3658